Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Langsjoen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biofactors (Oxford, England)|December 30, 2003
The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publicationsPeter H Langsjoen, Alena M Langsjoen
Biofactors (Oxford, England)|December 20, 2008
Supplemental ubiquinol in patients with advanced congestive heart failurePeter H Langsjoen, Alena M Langsjoen
Clinical Pharmacology in Drug Development|April 30, 2016
Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinonePeter H Langsjoen, Alena M Langsjoen
Angiology|September 27, 2008
Statin contraindicated in heart failureEddie Vos, Luca Mascitelli, Peter H Langsjoen
The Permanente Journal|September 10, 2019
Statin-Associated Cardiomyopathy Responds to Statin Withdrawal and Administration of Coenzyme Q<sub>10</sub>Peter H Langsjoen, Jens O Langsjoen, Alena M Langsjoen, et al.
Biofactors (Oxford, England)|July 29, 2006
Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuationPeter H Langsjoen, Jens O Langsjoen, Alena M Langsjoen, et al.
Biofactors (Oxford, England)|December 30, 2003
Statin cardiomyopathy? A potential role for Co-Enzyme Q10 therapy for statin-induced changes in diastolic LV performance: description of a clinical protocolMarc A Silver, Peter H Langsjoen, Szabolcs Szabo, et al.
The American Journal of Cardiology|November 16, 2004
Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunctionMarc A Silver, Peter H Langsjoen, Szabolcs Szabo, et al.
Expert Review of Clinical Pharmacology|February 7, 2015
Statins stimulate atherosclerosis and heart failure: pharmacological mechanismsHarumi Okuyama, Peter H Langsjoen, Tomohito Hamazaki, et al.
Journal of Clinical Medicine|July 29, 2023
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other ConsiderationsBeatrice A Golomb, Jun Hee Han, Peter H Langsjoen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biofactors (Oxford, England)|December 30, 2003
The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publicationsPeter H Langsjoen, Alena M Langsjoen
Biofactors (Oxford, England)|December 20, 2008
Supplemental ubiquinol in patients with advanced congestive heart failurePeter H Langsjoen, Alena M Langsjoen
Clinical Pharmacology in Drug Development|April 30, 2016
Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinonePeter H Langsjoen, Alena M Langsjoen
Angiology|September 27, 2008
Statin contraindicated in heart failureEddie Vos, Luca Mascitelli, Peter H Langsjoen
The Permanente Journal|September 10, 2019
Statin-Associated Cardiomyopathy Responds to Statin Withdrawal and Administration of Coenzyme Q<sub>10</sub>Peter H Langsjoen, Jens O Langsjoen, Alena M Langsjoen, et al.
Biofactors (Oxford, England)|July 29, 2006
Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuationPeter H Langsjoen, Jens O Langsjoen, Alena M Langsjoen, et al.
Biofactors (Oxford, England)|December 30, 2003
Statin cardiomyopathy? A potential role for Co-Enzyme Q10 therapy for statin-induced changes in diastolic LV performance: description of a clinical protocolMarc A Silver, Peter H Langsjoen, Szabolcs Szabo, et al.
The American Journal of Cardiology|November 16, 2004
Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunctionMarc A Silver, Peter H Langsjoen, Szabolcs Szabo, et al.
Expert Review of Clinical Pharmacology|February 7, 2015
Statins stimulate atherosclerosis and heart failure: pharmacological mechanismsHarumi Okuyama, Peter H Langsjoen, Tomohito Hamazaki, et al.
Journal of Clinical Medicine|July 29, 2023
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other ConsiderationsBeatrice A Golomb, Jun Hee Han, Peter H Langsjoen, et al.
Pageof 2